WO2009021978A3 - Carbaboranreste enthaltende verbindungen und deren verwendung in der medizin, insbesondere für die verwendung in der tumortherapie - Google Patents

Carbaboranreste enthaltende verbindungen und deren verwendung in der medizin, insbesondere für die verwendung in der tumortherapie Download PDF

Info

Publication number
WO2009021978A3
WO2009021978A3 PCT/EP2008/060649 EP2008060649W WO2009021978A3 WO 2009021978 A3 WO2009021978 A3 WO 2009021978A3 EP 2008060649 W EP2008060649 W EP 2008060649W WO 2009021978 A3 WO2009021978 A3 WO 2009021978A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
residue
glycosylamine
thioglycoside
glycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/060649
Other languages
English (en)
French (fr)
Other versions
WO2009021978A2 (de
Inventor
Sven Stadlbauer
Evamarie Hey-Hawkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leipzig University
Original Assignee
Leipzig University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leipzig University filed Critical Leipzig University
Publication of WO2009021978A2 publication Critical patent/WO2009021978A2/de
Publication of WO2009021978A3 publication Critical patent/WO2009021978A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6596—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Erfindung betrifft Verbindung der allgemeinen Formel (I) wobei A für Sauerstoff, Schwefel oder Selen steht, (CB)n und (CB)m stehen jeweils für ein Carbaboran oder eine Kette von Carbaboranen. R1 ist ausgewählt aus Hydroxy, Alkoxy, Alkenoxy, O-Glycosid, Thioglycosid und Glycosylamin, PO42- oder P2O73- und A-M+. R2 und R4 sind ausgewählt aus O-Glycosidrest, Thioglycosidrest, Glycosylaminrest, PO42- oder P2O73- und A-M+. R3 ist ausgewählt aus Alkoxy, Alkenoxy, O-Glycosid, Thioglycosid, Glycosylamin oder ein Phosphonatrest. Durch ihren Gehalt an Zuckerresten binden die erfindungsgemäßen Verbindungen spezifisch an Rezeptoren auf der Oberfläche von karzinogenen Zellen. Zusätzlich wirken die Verbindungen durch die Phosphonatgruppen als Phosphatmimetika, wodurch eine Bindung speziell an calciumreiches Tumorgewebe erfolgt. Vorteilhaft sind die Verbindungen selbst nicht toxisch, weisen eine geringe unspezifische Proteinbindung auf und sind gut wasserlöslich. Die Erfindung betrifft weiter die Verwendung dieser Verbindungen als Arzneimittel, insbesondere in der Radio-Onkologie, sowie Verfahren zu deren Herstellung und Zwischenprodukte, die während des Herstellungsverfahrens erhalten werden.
PCT/EP2008/060649 2007-08-13 2008-08-13 Carbaboranreste enthaltende verbindungen und deren verwendung in der medizin, insbesondere für die verwendung in der tumortherapie Ceased WO2009021978A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007038930A DE102007038930B4 (de) 2007-08-13 2007-08-13 Neue chemische Verbindung und deren Verwendung in der Medizin, insbesondere für die Verwendung in der Tumortherapie
DE102007038930.4 2007-08-13

Publications (2)

Publication Number Publication Date
WO2009021978A2 WO2009021978A2 (de) 2009-02-19
WO2009021978A3 true WO2009021978A3 (de) 2009-04-09

Family

ID=40090446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/060649 Ceased WO2009021978A2 (de) 2007-08-13 2008-08-13 Carbaboranreste enthaltende verbindungen und deren verwendung in der medizin, insbesondere für die verwendung in der tumortherapie

Country Status (2)

Country Link
DE (1) DE102007038930B4 (de)
WO (1) WO2009021978A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775449B (zh) * 2012-08-20 2014-10-08 聊城大学 1,7-间位二碳十硼烷羧酸三苯基氯化锡化合物、制备方法及其应用
JP6978420B2 (ja) 2015-09-17 2021-12-08 オハイオ・ステート・イノヴェーション・ファウンデーション カルボラン化合物及びその使用方法
CA3122029A1 (en) * 2018-12-03 2020-06-11 Ohio State Innovation Foundation Carborane compounds, carborane analogs, and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068584A1 (de) * 1981-06-30 1983-01-05 THE PROCTER & GAMBLE COMPANY Bor enthaltende Polyphosphonate für die Behandlung von Verkalkungstumoren
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
EP1113020A2 (de) * 1993-12-02 2001-07-04 Emory University Bor-cluster enthaltende Nukleoside und Oligonukleoside

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5630786A (en) 1994-06-27 1997-05-20 Ionix Corporation Boron neutron capture enhancement of fast neutron therapy
JPH1180177A (ja) 1997-09-04 1999-03-26 Toray Ind Inc ホウ素含有ビスホスホン酸化合物、その製造方法、およびその医薬用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068584A1 (de) * 1981-06-30 1983-01-05 THE PROCTER & GAMBLE COMPANY Bor enthaltende Polyphosphonate für die Behandlung von Verkalkungstumoren
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
EP1113020A2 (de) * 1993-12-02 2001-07-04 Emory University Bor-cluster enthaltende Nukleoside und Oligonukleoside

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALEXANDER, ROY P. ET AL: "Chemistry of decaborane-phosphorus compounds. VI. Phosphino-m-carboranes", INORGANIC CHEMISTRY (WASHINGTON, DC, UNITED STATES) , 5(3), 493-5 CODEN: INOCAJ; ISSN: 0020-1669, 1966, XP002508859 *
HILL, W. E. ET AL: "Preparation and characterization of di(tertiary phosphines) with electronegative substituents. 1. Symmetrical derivatives", INORGANIC CHEMISTRY , 17(9), 2495-8 CODEN: INOCAJ; ISSN: 0020-1669, 1978, XP002508858 *
S. STADLBAUER, P. LÖNNECKE, E. HEY-HAWKINS: "Phosphonate-substituted Carbaboranes for Potential Use in BNCT", ADVANCES IN NEUTRON CAPTURE THERAPY 2006, PROCEEDINGS OF ICNCT-12, CHEMISTRY AND PHARMACY, (EDS. Y. NAKAGAWA, T. KOBAYASHI, H. FUKUDA), 2006, pages 215 - 216, XP002513129, Retrieved from the Internet <URL:http://www.uni-leipzig.de/chemie/hh/index.php?lang=de&id=artik0507> [retrieved on 20090203] *
S. STADLBAUER, P. LÖNNECKE, E. HEY-HAWKINS: "Phosphonate-substituted Carbaboranes for Potential Use in BNCT", ADVANCES IN NEUTRON CAPTURE THERAPY, PROCEEDINGS OF ICNCT-12, CHEMISTRY AND PHARMACY, (EDS. Y. NAKAGAWA, T. KOBAYASHI, H. FUKUDA), 2006, pages 215 - 216, XP002513129 *

Also Published As

Publication number Publication date
DE102007038930B4 (de) 2013-12-05
WO2009021978A2 (de) 2009-02-19
DE102007038930A1 (de) 2009-02-19

Similar Documents

Publication Publication Date Title
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
SI1853602T1 (sl) Kemične spojine
PL1853588T3 (pl) Związki chemiczne
WO2003086306A3 (en) 5ht2c receptor modulators
WO2007087231A3 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007097931A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007136603A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
MX2008012490A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
MY150787A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of prevention of diabetes
JO2701B1 (en) Vehicles
UA96441C2 (ru) Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
WO2006121861A3 (en) Biphenylazetidinone cholesterol absorption inhibitors
MX2007008924A (es) Compuestos quimicos.
WO2008005565A3 (en) Antiviral phosphinate compounds
WO2009016410A3 (en) Chemical compounds 831
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2007070434A3 (en) Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
MX2010007948A (es) Inhibidores de proteinas de apoptosis.
WO2009062576A8 (en) Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08787200

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08787200

Country of ref document: EP

Kind code of ref document: A2